RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee’s recommendations.
More from 51¶¯Âþ
Explore the latest news, articles and features
Health
The mysterious reason why women get hotter from age 18 to 42
51¶¯Âþ
Comment
This is the most underrated sci-fi film franchise of the 21st century
Culture
Comment
Shiver me timbers: Do we have to worry about space pirates now?
Regulars
Life
PMOS shows us why many scientific terms need to be renamed
Leader
Popular articles
Trending 51¶¯Âþ articles
1
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
2
Mystery of the ancient giant stone jars of Laos may have been solved
3
The ‘doomsday’ glacier’s giant ice shelf is about to break away
4
The distant world that is our best hope of finding alien life
5
We may finally know why dinosaurs like T. rex evolved tiny arms
6
First test of CO2 removal with green sand finds no harm to marine life
7
After news about Oliver Sacks's "lies", we revisit his best-loved book
8
We could generate hydrogen from rocks while storing CO2 in them
9
Solar farm on the ocean outperforms land-based solar in Taiwan
10
The mysterious reason why women get hotter from age 18 to 42
